drugset / Trial / NCT06895460
A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)
Phase 3
Not yet recruiting
198 enrolled
The First Affiliated Hospital with Nanjing Medical University
RandomizedParallel-groupDouble-blindTreatment
Summary
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial on the Treatment of Bronchial Asthma with Budesonide Formoterol Combined with Immune Modulators (Staphylococcus and Neisseria Tablets)
Timeline
- Start
- 2025-06-20
- Primary completion
- 2027-06-30
- Completion
- 2027-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Staphylococcus and Neisseria Tablets | Unknown | 1.2 mg | — |
| Background | Symbicort | Unknown | — | Inhaled |